Discover 1,973 paid clinical trials in Fort Lauderdale, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,973
ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
for
Gastrointestinal Stromal Tumors
Location: Miami FL
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT05366816
Phase2, Recruiting
Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)
for
Peripheral Nerve Injury
Location: Miami FL
Sponsor: W. Dalton Dietrich
Sex: All
Age: 18 - 65
Code: NCT05541250
Phase1, Recruiting
Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms
for
Cerebral Aneurysm
Location: Miami FL
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT04141020
Phase2, Recruiting
PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors
Get alerts for new trials in your area by subscribing now
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
for
Crohn Disease
Location: Miami FL
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT06774079
Recruiting
Targeted Navigation in Hepatocellular Carcinoma (HCC)
for
Hepatocellular Carcinoma, Cholangiocarcinoma,
Location: Miami FL
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT06260943
Recruiting
The University of Miami Adapt (UAdapt) Trial
for
Prostate Cancer
Location: Miami FL
Sponsor: University of Miami
Sex: Male
Age: 35 - 70+
Code: NCT06111313
Phase2, Recruiting
Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma
for
CNS Lymphoma
Location: Miami FL
Sponsor: Juan P. Alderuccio, MD
Sex: All
Age: 18+
Code: NCT06730542
Phase1, Recruiting
Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
for
Recurrent Glioblastoma
Location: Miami FL
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT05284643
Recruiting
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
for
Lung Diseases
Location: Miami FL
Sponsor: University of Miami
Sex: All
Age: 18 - 70+
Code: NCT06494033
Recruiting
Clinical Research in ALS Study
for
Amyotrophic Lateral Sclerosis
Location: Miami FL
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT00136500
Recruiting
Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)
for
Multiple Myeloma
Location: Miami FL
Sponsor: Carl Ola Landgren, MD, PhD
Sex: All
Age: 18+
Code: NCT06100237
Phase2, Recruiting
A Novel Repetitive Synchronized Associative Stimulation Neuromodulation Approach for Spinal Cord Injury Patients
for
SCI - Spinal Cord Injury
Location: Miami FL
Sponsor: University of Miami
Sex: All
Age: 18 - 70
Code: NCT06494059
Recruiting
Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma
for
Mantle Cell Lymphoma
Location: Miami FL
Sponsor: Alvaro Alencar, MD
Sex: All
Age: 18+
Code: NCT06029309
Phase1, Phase2, Recruiting
A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Non-Healing Diabetic Foot Ulcers
for
Diabetic Foot Ulcers
Location: Miami FL
Sponsor: PRP Concepts, LLC
Sex: All
Age: 18+
Code: NCT02312596
Recruiting
A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Venous Leg Ulcers
for
Venous Leg Ulcers
Location: Miami FL
Sponsor: PRP Concepts, LLC
Sex: All
Age: 18+
Code: NCT02312518
Recruiting
A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Pressure Ulcers
Location: Boynton Beach FL, Miami FL, Indianapolis IN,
Sponsor: Innovative Medical
Sex: All
Age: 18+
Code: NCT01278420
Recruiting
Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy